Connect to other sites within the UBM Medica Network
NIH Launches Major Coordinated Effort to Understand Lupus and RA
Backed by 6 drug firms and 4 foundations, the National Institutes of Health has created a large network of top researchers charged wtih collaborating to comprehend lupus and rheumatoid arthritis at the cellular and molecular level.
Fatigue: The “Invisible Disease” in RA
Chronic fatigue in rheumatoid arthritis is common, has been compared to that in cancer, and is not resolved by treating inflammation. But there are ways to assess and address it.
Lean RA Patients At Greater Risk of Progression
(AUDIO) Rheumatoid arthritis patients with low or normal body mass index have a greater risk of progression on X-ray or MRI, according to a large study.
Discontinued for RA, Tabalumab Looks Good in Extension Trial
The B-cell depleter tabalumab proved effective in a long-term trial, but only after its maker had stopped development for rheumatoid arthritis.
Which Older Patients Most Risk Liver Toxicity From MTX?
A large study of veterans reveals factors that predict which people starting methotrexate for rheumatic diseases after the age of 65 will quickly begin to show signs of liver damage.
Obesity Stymies RA Treatment. But Why?
Being overweight or obese not only increases the risk of rheumatoid arthritis developing in the first place; it also makes RA worse and decreases chances for remission.
Rasuvo Offers New "Niche" Options for MTX Auto-Injection
A new auto-injectable form of methotrexate offers 10 dosage options. Is this an important advantage for medication management and adherence over the four already available?
By clicking Accept, you agree to become a member of the UBM Medica Community.